In Vivo CD8+ CAR-T Program Preclinical genetic-medicine program using targeted lipid nanoparticles to generate functional CD8-positive CAR-T cells and drive deep B-cell depletion.
Visit productCosigns Received
Be the first Cosign
Put your name behind In Vivo CD8+ CAR-T Program.
Add it to your Products I use list and share why you use it.